|
4 min., 45 sec.
|
Programs
Latest program rundownComing up:
Latest Features:
June 20, 2013 | NPR ·
June 20, 2013 | NPR ·
June 20, 2013 | NPR ·
Latest program rundownComing up:
Latest Features:
June 19, 2013 | NPR ·
June 19, 2013 | NPR ·
June 19, 2013 | NPR ·
Latest Saturday rundownWE Saturday Feature
June 15, 2013 | NPR ·
Latest Sunday rundown
WE Sunday Feature
June 16, 2013 | NPR ·
rheumatoid arthritis
Nov 7, 2012 — Xeljanz, a new rheumatoid arthritis drug, is the first one that works by blocking enzymes called janus kinases. They play a communication role inside the body and are involved in inflammation associated with rheumatoid arthritis.
Comments |


on:



